Terms: = Lung cancer AND ZFHX3, ATBT, 463, ENSG00000140836, Q15911 AND Prognosis
33 results:
1. Real-World Clinical Outcomes for Patients with
Li K; Bosdet I; Yip S; Ho C; Laskin J; Melosky B; Wang Y; Sun S
Curr Oncol; 2023 Jul; 30(8):7099-7111. PubMed ID: 37622996
[TBL] [Abstract] [Full Text] [Related]
2. Regional lymph node recurrence after stereotactic body radiation therapy for lung cancer: Patterns of recurrence, treatment approaches, and clinical outcomes (KROG 21-09).
Lee TH; Shin H; Ahn YC; Kang MK; Song C; Kim WC; Moon SH; Kim JH; Cho J; Park HJ; Lee HK; Kim BH; Kim HJ
Radiother Oncol; 2023 Jun; 183():109572. PubMed ID: 36822359
[TBL] [Abstract] [Full Text] [Related]
3. Prognostic value of complex glandular patterns in invasive pulmonary adenocarcinomas.
Bossé Y; Gagné A; Althakfi W; Orain M; Fiset PO; Desmeules P; Joubert P
Hum Pathol; 2022 Oct; 128():56-68. PubMed ID: 35872155
[TBL] [Abstract] [Full Text] [Related]
4. Patients deriving long-term benefit from immune checkpoint inhibitors demonstrate conserved patterns of site-specific mutations.
Principe DR
Sci Rep; 2022 Jul; 12(1):11490. PubMed ID: 35798829
[TBL] [Abstract] [Full Text] [Related]
5. Prognostic value of pre-treatment advanced lung cancer inflammation index in non-small cell lung cancer: a meta-analysis.
Tang Y; Ji Y; Yang M
Biomarkers; 2022 Jul; 27(5):441-447. PubMed ID: 35297277
[TBL] [Abstract] [Full Text] [Related]
6. Prognostic effect of coexisting TP53 and zfhx3 mutations in non-small cell lung cancer patients treated with immune checkpoint inhibitors.
Zhang L; Zhang T; Shang B; Li Y; Cao Z; Wang H
Scand J Immunol; 2021 Sep; 94(3):e13087. PubMed ID: 35226388
[TBL] [Abstract] [Full Text] [Related]
7. prognosis of epidermal growth factor receptor-mutated stage I lung adenocarcinoma with radiologically solid features.
Hattori A; Matsunaga T; Fukui M; Takamochi K; Suzuki K
Eur J Cardiothorac Surg; 2022 Mar; 61(4):769-777. PubMed ID: 34791156
[TBL] [Abstract] [Full Text] [Related]
8. The impact of primary tumor location on prognosis after colorectal lung metastasectomy.
Sponholz S; Oguzhan S; Mese M; Schirren M; Kirschbaum A; Schirren J
Int J Colorectal Dis; 2021 Aug; 36(8):1731-1737. PubMed ID: 33712904
[TBL] [Abstract] [Full Text] [Related]
9. Operative invasiveness does not affect the prognosis of patients with non-small cell lung cancer.
Motono N; Iwai S; Iijima Y; Usuda K; Uramoto H
BMC Pulm Med; 2020 Oct; 20(1):265. PubMed ID: 33059654
[TBL] [Abstract] [Full Text] [Related]
10. Integrative analysis of genomic alteration, immune cells infiltration and prognosis of lung squamous cell carcinoma (LUSC) to identify smoking-related biomarkers.
Li J; Li H; Zhang C; Zhang C; Wang H
Int Immunopharmacol; 2020 Dec; 89(Pt A):107053. PubMed ID: 33045568
[TBL] [Abstract] [Full Text] [Related]
11. zfhx3 mutation as a protective biomarker for immune checkpoint blockade in non-small cell lung cancer.
Zhang J; Zhou N; Lin A; Luo P; Chen X; Deng H; Kang S; Guo L; Zhu W; Zhang J
Cancer Immunol Immunother; 2021 Jan; 70(1):137-151. PubMed ID: 32653938
[TBL] [Abstract] [Full Text] [Related]
12. Both the presence of a micropapillary component and the micropapillary predominant subtype predict poor prognosis after lung adenocarcinoma resection: a meta-analysis.
Wang W; Hu Z; Zhao J; Huang Y; Rao S; Yang J; Xiao S; Cao R; Ye L
J Cardiothorac Surg; 2020 Jun; 15(1):154. PubMed ID: 32600473
[TBL] [Abstract] [Full Text] [Related]
13. Meta-analysis of diagnostic and prognostic value of miR-126 in non-small cell lung cancer.
Sun L; Zhou H; Yang Y; Chen J; Wang Y; She M; Li C
Biosci Rep; 2020 May; 40(5):. PubMed ID: 32329507
[TBL] [Abstract] [Full Text] [Related]
14. Transcriptomic analysis and identification of prognostic biomarkers in cholangiocarcinoma.
Li H; Long J; Xie F; Kang K; Shi Y; Xu W; Wu X; Lin J; Xu H; Du S; Xu Y; Zhao H; Zheng Y; Gu J
Oncol Rep; 2019 Nov; 42(5):1833-1842. PubMed ID: 31545466
[TBL] [Abstract] [Full Text] [Related]
15. Prognostic factors for survival in patients with completely resected pN2 non-small-cell lung cancer.
Sezen CB; Aksoy Y; Sonmezoglu Y; Citak N; Saydam O; Metin M
Acta Chir Belg; 2021 Feb; 121(1):23-29. PubMed ID: 31437115
[TBL] [Abstract] [Full Text] [Related]
16. lung cancer after lung transplantation: An analysis of 25 years of experience in a single institution.
Chatron E; Dégot T; Salvaterra E; Dumazet A; Porzio M; Hirschi S; Schuller A; Massard G; Renaud-Picard B; Kessler R
Clin Transplant; 2019 Jan; 33(1):e13446. PubMed ID: 30415483
[TBL] [Abstract] [Full Text] [Related]
17. Free‑floating cancer cells in lymph node sinuses of hilar lymph node‑positive patients with non‑small cell lung cancer.
Nakamura Y; Mukai M; Hiraiwa S; Kishima K; Sugiyama T; Tajiri T; Yamada S; Iwazaki M
Mol Med Rep; 2018 Jul; 18(1):1081-1087. PubMed ID: 29767232
[TBL] [Abstract] [Full Text] [Related]
18. Epidermal Growth Factor Receptor Mutation as a Risk Factor for Recurrence in lung Adenocarcinoma.
Hayasaka K; Shiono S; Matsumura Y; Yanagawa N; Suzuki H; Abe J; Sagawa M; Sakurada A; Katahira M; Takahashi S; Endoh M; Okada Y
Ann Thorac Surg; 2018 Jun; 105(6):1648-1654. PubMed ID: 29486179
[TBL] [Abstract] [Full Text] [Related]
19. Clinical significance of preoperative serum albumin level for prognosis in surgically resected patients with non-small cell lung cancer: Comparative study of normal lung, emphysema, and pulmonary fibrosis.
Miura K; Hamanaka K; Koizumi T; Kitaguchi Y; Terada Y; Nakamura D; Kumeda H; Agatsuma H; Hyogotani A; Kawakami S; Yoshizawa A; Asaka S; Ito KI
Lung Cancer; 2017 Sep; 111():88-95. PubMed ID: 28838406
[TBL] [Abstract] [Full Text] [Related]
20. Analysis of radioiodine therapy and prognostic factors of differentiated thyroid cancer patients with pulmonary metastasis: An 8-year retrospective study.
Wang R; Zhang Y; Tan J; Zhang G; Zhang R; Zheng W; He Y
Medicine (Baltimore); 2017 May; 96(19):e6809. PubMed ID: 28489758
[TBL] [Abstract] [Full Text] [Related]
[Next]
